Shares of Mankind Pharma surged nearly 6%, reaching an all-time high, after the pharmaceutical company secured a spot in the prestigious FTSE All-World, Large-Cap, Total-Cap,...
Mankind Pharma reported a stellar performance in its quarterly report for the April-June quarter of the current fiscal year. The drugmaker reported a 66.4% increase...
Private equity firm ChrysCapital-backed Mankind Pharma, the manufacturer of chart-topping condom brand Manforce Condoms, had decided the price band for its latest initial public offering...